Isomorphic Labs raises 5 billion dollars to advance AI drug design
Isomorphic Labs has closed a 5 billion dollar Series C investment round to advance its AI drug design software toward clinical trials.
FTMQ SI, written by our newsroom0 views
Isomorphic Labs Ltd. has raised 5 billion dollars in a Series C funding round, Google News, TechCrunch AI, SiliconANGLE AI, and Bloomberg.com all report. TechCrunch AI and BigGo Finance report that the company plans to use the new capital to take its drug candidates into clinical trials. EU-Startups reports the transaction value as 4.5 billion euros. [1][2][3][8][10]
The financing round was co-led by venture capital firms Greenoaks and Sequoia Capital, according to TechCrunch AI, SiliconANGLE AI, and Bloomberg.com. TechCrunch AI reports that new investor Andreessen Horowitz joined the funding round. SiliconANGLE AI and TechCrunch AI report that parent company Alphabet Inc. also invested in the round alongside its venture divisions GV and CapitalG. TechCrunch AI notes that Thrive Capital, MGX, Temasek, and the U.K. Sovereign AI Fund participated as well. [2][3][4][8]
Isomorphic Labs offers an artificial intelligence software platform called the Isomorphic Labs Drug Design Engine, or IsoDDE. The technology models complex biological processes, enhances protein-ligand structure predictions, and calculates binding affinity to assist in rational drug design. The company was founded by Chief Executive Officer Demis Hassabis and incorporated on February 24, 2021, as a British multinational spin-off from Alphabet research lab DeepMind [12, 13]. Max Jaderberg serves as president of the firm [14]. [3][12][13][14]
As FTMQ SI reported earlier, Isomorphic Labs previously negotiated funding at an estimated valuation between 40 billion and 50 billion dollars. The company released its IsoDDE software platform in February 2026, building on research from DeepMind's AlphaFold system [13, 15]. IsoDDE operates as a computational tool rather than a therapeutic drug candidate [13]. [13][15]
In short
- Isomorphic Labs raised 5 billion dollars in a Series C funding round.
- Greenoaks and Sequoia Capital co-led the investment round.
- The funding will help advance AI-designed drug candidates to clinical trials.
- Isomorphic Labs operates the IsoDDE AI drug design platform.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Isomorphic Labs raises $5 billion to design drugs with AIPasquale Pillitteri, 11h ago (the report this story comes from)
- [2]Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trialsTechCrunch AI, 13h ago
- [3]Alphabet’s Isomorphic Labs raises $5B to accelerate drug discovery with AISiliconANGLE AI, 4h ago
- [4]Isomorphic Labs raises $5bn backed by Sequoia and A16zSifted AI, 15h ago
- [5]Hassabis-Backed Isomorphic Labs Lands $5 Billion Series C to Push AI-Designed Drugs Toward TrialsBigGo Finance, 13h ago
- [6]How Isomorphic Labs Makes Money: From AlphaFold to DrugsFourWeekMBA, 14h ago
- [7]Isomorphic Labs announces Series C investment roundIsomorphic Labs, 16h ago
- [8]Sequoia, Greenoaks Lead Isomorphic Labs $5 Billion Funding RoundBloomberg.com, 14h ago
- [9]Isomorphic Labs raises USD 5 billion in landmark AI drug discovery financingAllSci, 15h ago
- [10]AI drug discovery giant Isomorphic Labs raises €4.5 billion in blockbuster funding roundEU-Startups, 12h ago
- [11]Isomorphic Labs Raises $5 Billion for AI Drug DesignThe Defiant, 15h ago
Background
- [12]Isomorphic Labs on Wikipedia
- [13]Isomorphic Labs on Grokipedia
- [14]Isomorphic Labs targets AI driven cancer treatments FTMQ SI, 17d ago
- [15]Alphabet spinoff Isomorphic Labs seeks funding at forty billion dollar valuation FTMQ SI, 40d ago
Our newsroom writes these reports with the help of software, from the 15 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ SI
Earlier reports of ours on the same people and subjects.
- Isomorphic Labs targets AI driven cancer treatmentsIndustry Labs, 17d ago
- Alphabet spinoff Isomorphic Labs seeks funding at forty billion dollar valuationModels & Products, 40d ago
- Pathos AI raises 237 million dollars in Series E roundModels & Products, 25d ago
- Google DeepMind executive claims widening gap between closed and open AI modelsIndustry Labs, 3d ago
- OpenAI reportedly raises 11 billion dollars at 1.25 trillion dollar valuationIndustry Labs, 10d ago
More in Industry Labs
- OpenAI releases GPT-6.2 Astra and Sol models4h ago
- Anthropic moves to float as major tech firms hold key stakes4h ago
- OpenAI moves forward with AMD partnership to diversify compute infrastructure4h ago
- Microsoft Research releases TokenEconomizer plugin to lower coding agent token usage1d ago
- Demonstrators rally in San Francisco demanding international treaty on advanced AI2d ago
- Google DeepMind executive claims widening gap between closed and open AI models3d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.